ArticleJournal of experimental & clinical cancer research : CR2025

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation.

Jingwen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.